Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dac g 6 is a major protein allergen derived from the pollen of Dactylis glomerata, commonly known as Orchard grass or Cocksfoot grass (UniProt P43215). It belongs to the Group 6 grass pollen allergens, which are typically small, acidic proteins with a molecular weight of approximately 11-12 kDa (WHO/IUIS Allergen Nomenclature). In sensitized individuals, Dac g 6 binds to specific IgE antibodies on the surface of mast cells and basophils, triggering the release of inflammatory mediators that cause symptoms of allergic rhinitis, conjunctivitis, and asthma (PubMed: 7521631). While its exact biological function in the plant is not fully characterized, it is a critical target in the diagnosis and treatment of seasonal allergies. Therapeutic intervention involves allergen-specific immunotherapy (AIT), where controlled exposure to the allergen aims to desensitize the immune system and induce long-term tolerance (PubMed: 29055014). Monitoring of Dac g 6-specific IgE and IgG4 levels is often used to assess patient sensitivity and the efficacy of treatment.
Allergen-specific immunotherapy (AIT) works by inducing immune tolerance through the administration of increasing doses of the allergen, leading to a shift from a Th2 to a Th1 immune response, the production of regulatory T cells, and the induction of allergen-specific IgG4 antibodies that block IgE-mediated mast cell activation (PubMed: 29055014).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Major allergen Dac g 6 (Dac g 6).